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Binding of laminin to glycolipids of neuronal membranes was studied with a thin-layer chromatography 
overlay assay. The major brain ganglioside GDIA was the main binding component, when chromatograms 
containing the same molar amount of the different brain gangliosides and the brain sulfatide were incubated 
with iaminin at physiological ionic strength. The possible role of laminin binding to brain gangliosides in 
laminin-neuron interactions was studied with adhesion assays. It was found that binding of.rat brain neu- 
rons to laminin is blocked by lo-40 PM brain gangliosides but not by sulfatide. The inhibition by the gan- 
gliosides is suggested to be due to competition with the cell surface interaction sites of laminin and not to 
binding of the gangliosides to the cells. Our findings support the idea that the adhesive and neurite-promot- 
ing effect of laminin is dependent on its interaction with gangliosides at the neuronal cell surfaces. 
Laminin; Ganglioside; Cell adhesion; Neurite outgrowth; (Brain) 
1. INTRODUCTION 
Laminin is a high-& glycoprotein first 
characterized as a constituent of basement mem- 
branes [2]. It may be involved in the interactions of 
peripheral neurons with surrounding basal lamina 
and in those of central neurons with glial cells, 
which can express Iaminin [3]. 
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Abbreviations: BSA, bovine serum albumin; DMEM, 
Dulbecco’s modified Eagle’s medium; PBS, phosphate- 
buffered saline (137 mM NaCl, 2.7 mM KCI, 8.1 mM 
Na2HP04, 1.5 mM KHzPOd, 0.7 mM CaC12, 0.5 mM 
MgC12, pH 7.4); SDS-PAGE, SDS-polyacrylamide gel 
electrophoresis; TLC, thin-layer chromatography. The 
shorthand nomenclature of Svennerholm [l] is used for 
gangliosides 
Previous studies have shown that initiation of 
neurites in neuroblastoma cells on surfaces coated 
with conditioned media from C6 glioma cells can 
be blocked by an excess of gangliosides in assay 
media [4]. It was therefore suggested that cell sur- 
face gangliosides are involved in the mechanism of 
contact-dependent neurite outgrowth [4]. Because 
the neurite-promoting effect of various condition- 
ed media appears to be mainly due to Iaminin [5], 
we decided to study whether the effect of 
gangliosides could be due to an interaction with 
laminin. This study shows that laminin binds to 
neuronal gangliosides, and this binding may be im- 
portant in cell attachment o and neurite initiation 
on laminin. 
2. EXPERIMENTAL 
2 _ f . ~a~eriafs 
Laminin was purchased from Bethesda Research 
Laboratories (Neu Isenburg, FRG), or was 
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purified from mouse sarcoma by gel filtration [2] 
followed by affinity chromatography on heparin- 
Sepharose [6]. Anti-laminin was purchased from 
Bethesda Research Laboratories. The laminin 
bands of 200 and 400 kDa transferred from SDS- 
PAGE [7] to nitrocellulose [8] were used for the 
purification of anti-laminin [9]. 
Bovine brain sulfatide (galactosylceramide 
sulfate), heparin and colominic acid were pur- 
chased from Sigma (MO, USA). Gangliosides were 
extracted from pig brain and purified by anion- 
exchange chromatography [lo] followed by 
chromatography on Iatrobeads 6RS-8060 silica gel 
123 
L 
Fig.1. SDS-PAGE and immunoblotting of laminin. 
Lane 1, 10 ,ug laminin on a 5-20% polyacrylamide gel 
stained with Coomassie blue. Lanes 2 and 3, 3 pg 
laminin separated by SDS-PAGE and transferred to 
nitrocellulose at 100 V for 4 h in a buffer containing 
25 mM Tris and 192 mM glycine, pH 8.3. Detection 
with a commercial antibody (1: 1000, Bethesda Research 
Laboratories) and with an antibody affinity-purified 
thereof is shown on lanes 2 and 3, respectively. The 
numbers on the right give the calibration in kDa. 
[ 1 I]. The concentrations of different gangliosides 
were measured with a resorcinol method [12]. 
2.2. Binding of laminin to glycolipids separated 
on TLC 
Glycolipids were chromatographed on alu- 
minum-backed high-performance TLC plates 
precoated with silica gel 60 (Merck, Darmstadt) in 
chloroform/methanol/2.5 N ammonia (60: 35 : 8, 
by vol.). The plates were air-dried, and strips cut 
from the plates were dipped for 1 min in 0.1% 
(w/v) polyisobutylmethacrylate (Rohm, Darm- 
stadt) in n-hexane [13]. To block non-specific 
binding sites, the TLC strips were sprayed with 
10 mg/ml of BSA in PBS and then incubated in 
the same buffer for 1 h. The strips were washed 
twice with PBS, and were then incubated with 
10 pg/ml of laminin in PBS containing 5 mg/ml of 
BSA (buffer A) for 3 h at room temperature. The 
Fig.2. Equimolar mixtures of purified glycolipids 
analyzed by TLC and laminin overlay. (A) A TLC strip 
stained for hexose with 0.1% orcinol-3% HzSO~. Left 
lane, 3 nmol of each glycolipid. Right lane, 6 nmol of 
each glycolipid. (B) A replica analyzed by laminin 
overlay (see section 2 for details of the assay). 
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bound laminin was detected by incubating the 
strips with the commercial anti-laminin (1: 1000 in 
buffer A for 1 h) followed by peroxidase- 
conjugated goat anti-rabbit IgG (BioRad, Rich- 
mond, USA; 1:3000 in buffer A for 1 h). The 
strips were washed between the incubations three 
times with PBS. The peroxidase was detected with 
4-chloro-1-naphthol according to the manufac- 
turer’s instructions (BioRad). 
2.3. Cell attachment and neurite initiation on 
surfaces coated with laminin 
Cells from cerebral hemispheres of 17-19-day- 
old rat embryos were dispersed and allowed to 
adhere on poly(L-lysine)-coated tissue culture 
dishes as in [14]. The cells were used for adhesion 
assays within 4 days. Fluorescence microscopy of 
cells stained with monoclonal anti-neurofilament, 
anti-glial fibrillary acidic protein and anti-vimentin 
(Labsystems, Helsinki; staining according to the 
manufacturer’s instructions) indicated that 
70-80% of the cells used in the experiments were 
neurofilament-positive neurons. The rest of the 
cells were mainly astrocytes staining for glial 
fibrillary acidic protein. Adhesion assays were car- 
ried out with cells metabolically labeled with 14C- 
amino acids as described for neuroblastoma cells 
[4]. Laminin (25 ,ug/ml) was coated for -20 h at 
4°C on polystyrene wells (Greiner; diameter 
3.5 cm) that were washed with PBS and coated 
with 1 mg/ml of BSA for 1 h at room temperature 
before addition of cells. Cells were incubated in the 
wells in serum-free DMEM containing 6 mg/ml 
glucose (0.75 x IO6 cells in 1 ml total volume; 
15000-30000 cpm) for 1 h in an atmosphere of 
5% COz/95% air at 37°C. To remove non- 
adherent cells the wells were then rotated on a 
Bellco shaker at 140 rpm for 5 min followed by 
three washes with 1 ml assay medium. About 
55-60070 of cells adhered to surfaces coated with 
laminin followed by BSA, and 15-20% to surfaces 
treated with BSA. Specific binding to laminin in 
different experiments was calculated as the dif- 
ference of these values. Neurite outgrowth assays 
with N 18 neuroblastoma cells were carried out ac- 
cording to [4]. 
Fig. 
orci 
3. Effect of salt concentration on the binding of laminin to glycolipids. (A) Glycolipids stained for hexose with 0. 
nol-3% H2S04. Left lane, 3 nmol of each glycolipid; right lane, 15 nmol sulfatide. Strips B-H contain 
glycolipids as in A; they were analyzed with laminin overlay at increasing concentrations of NaCI. 
1070 
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3. RESULTS 
3.1. Laminin binds to brain gangliosides 
The purified laminin was composed of the 
characteristic 200- and 400-kDa polypeptides, as 
shown on SDS-PAGE stained with Coomassie blue 
(fig. 1, lane 1). Western blotting of the isolated 
laminin showed that the commercial anti-laminin 
used detects the 200- and 400-kDa polypeptides 
(fig.1, lane 2), whereas the affinity-purified an- 
tibody only detects the 200-kDa polypeptide (fig. 1, 
lane 3). 
An equimolar mixture of the major brain 
gangliosides and the brain sulfatide (3 and 6 nmol 
each) was used in a TLC overlay assay to study the 
binding of laminin to glycolipids. Fig.2A shows a 
TLC strip stained with orcinol for hexose, and 
fig.ZB a replica incubated with laminin, which was 
then detected with anti-laminin followed by a 
peroxidase-conjugated anti-rabbit IgG as was also 
used in the Western blotting (fig.1, lane 2). The 
major binding component in the equimolar mix- 
ture was the GDIA ganglioside. Lower amounts of 
laminin were bound to GMi, GTio and GQin 
gangliosides, and little if any binding was observed 
to the sulfatide under the conditions used (fig.2). 
Overlay with laminin purified by us (fig.1) or with 
commercial laminin gave similar results. The 
results were similar, when either the commercial 
antibody or the affinity-purified antibody was 
used to detect laminin bound to the TLC bands. 
The binding of laminin to gangliosides was 
strongly dependent on ionic strength during the 
overlay. Fig.3 shows that laminin binds to brain 
T 
f 
control co~lu$tic sulfetide GM1 
2SmgIml lOO@4 KK)kJM 
T 
I- 
Fig.4. Ganglioside inhibition of binding of rat brain neurons to laminin. The gangliosides and other substances to be 
tested were dialyzed against the serum-free DMEM used in the adhesion assay. The test substances were added to the 
wells at 2-times the final concentrations (indicated in the figure), and were allowed to bind to the surfaces for 0.5 h 
at 37°C. The cells were then added, and the adhesion assays were carried out as described in section 2. The bars indicate 
the mean f the range from triplicate wells. TLC of purified gangliosides used in the assays i  shown in the inset; 3 nmol 
of each ganglioside stained with 0.1% orcinol3% HzS04. 
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gangliosides at physiological ionic strength, but lit- 
tle if any binding is observed at 225-300 mM 
NaCl. In contrast, laminin binds to sulfatide even 
better at 250-300 mM salt as compared to 
physiological ionic strength (fig.3). 
3.2. Gangliosides block ceil attachment and 
neurite initiation on surfaces coated with 
laminin 
Binding of rat brain cells to laminin-coated sur- 
faces was inhibited when lo-40 pM GD~A or GTin 
ganglioside was added to the assay media (f&.4). 
The GM, ganglioside was a clearly less potent in- 
hibitor, and colominic acid (polysialic acid) or 
sulfatide did not block cell attachment o Iaminin 
(fig.4). When the Iaminin-coated surfaces were 
preincubated for 1 h with 100,~M GD~A 
ganglioside, which was then washed away before 
the cells were added, there was only a slight inhibi- 
tion in cell attachment (85% of control in specific 
binding, cf. fig.4). Respective experiments were 
carried out, in which the cells were incubated with 
gangliosides, the cells were centrifuged, resuspend- 
ed and then immediately subjected to binding 
assays. No inhibition was observed in such ex- 
periments, when the cells were preincubated for 
1 h with IOOpM GD~A ganglioside (107% of con- 
trol, cf. fig.4) suggesting that the inhibition 
observed is not due to binding of the gangliosides 
to cells during the assay. 
A similar inhibitory effect was observed when 
initiation of neuritic processes in the rat brain cells 
or neuroblastoma cells on laminin-coated surfaces 
was estimated. This is shown in fig.5 for N 18 
neuroblastoma cells. Most cells have initiated 
neuritic processes within the 5 h incubation on 
laminin (fig.5A). The neurite-promoting effect of 
laminin is not blocked by a high concentration of 
Fig.5. Ganglioside inhibition of neurite initiation in N 18 neuroblastoma cells on laminin in a 5 h assay at 37% 
Surfaces: A, B, and D were coated with laminin (25 @g/ml); C is a plastic surface. Test substances added to the assay 
media: A and C, none; B, 5 mg/ml heparin; D, 1OOpM GTla. Bar, 100,zm. 
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heparin (fig.SB) whereas the ganglioside (fig.SD) 
reduces the extent of neurite initiation to the level 
seen on plastic (fig.SC). 
4. DISCUSSION 
Here, we have used a TLC overlay assay to iden- 
tify neuronal surface structures that might be of 
importance in laminin-neuron interaction. 
Laminin bound to the TLC bands has been 
detected by specific staining with anti-laminin 
(fig. l), because chemical modification during 
iodination of laminin tends to reduce its binding to 
glycolipids (Laitinen, J. and Rauvala, H., un- 
published). We have used a physiological salt solu- 
tion during laminin overlay, and blocked 
nonspecific binding with about 5000-fold molar 
excess of BSA. The major binding component 
under these conditions is the GD~A ganglioside, 
when different glycolipids are studied at equimolar 
amounts (fig.2). Binding of laminin to gangliosides 
is blocked by high salt, whereas laminin appears to 
bind to sulfatide even better at 250-300 mM NaCl 
as compared to physiological ionic strength (fig.3). 
The possibility that the binding of laminin to 
brain gangliosides is important in laminin-neuron 
interaction is suggested by the finding that the 
adhesive and neurite-promoting effect can be 
blocked by the GD~A and GTia gangliosides (figs 
4,5), which are major gangliosides of brain and 
have the same terminal trisaccharide sequences 
[15]. The concentrations required for the in- 
hibitory effects (lo-40 PM) are reasonably low as 
compared to the inhibitory concentrations ob- 
served in some other adhesion assays [161. The ter- 
minal sialic acid residue is apparently required for 
the inhibitory effect, because the GM1 ganglioside 
has only a slight effect (fig.4). Further experiments 
are required to determine whether the inhibitory 
effect on the laminin-neuron interaction is retained 
by the isolated oligosaccharides or requires clusters 
of sialic acid-terminating oligosaccharides found 
in polymeric forms of the GDrn and GTra 
gangliosides. Sulfatide, heparin or polysialic acid 
do not appreciably inhibit the laminin-neuron in- 
teraction (figs 4,5). The pattern of and the concen- 
trations required for the inhibitory effects are quite 
similar as compared to the inhibition of the 
neurite-promoting effect of the conditioned 
medium from C6 glioma cells [4]. The inhibition 
by gangliosides in both assays can thus be explain- 
ed by interaction of the gangliosides with laminin, 
which appears to cause neurite-promoting effects 
in various conditioned media [5]. 
Gangliosides have been shown to block the ag- 
glutination of glutaraldehyde-fixed erythrocytes by 
laminin [17]. More recent studies by Roberts et al. 
[l&19] have, however, indicated that the binding 
sites of laminin in erythrocytes are provided by 
sulfatide rather than the gangliosides. Further- 
more, pretreatment of erythrocytes by gangliosides 
followed by washing inhibited laminin-mediated 
hemagglutination [19]. An indirect effect of 
gangliosides on the sulfatide-laminin interaction 
was suggested [ 191. In the case of brain neurons we 
did not observe an indirect effect by pretreatment 
of the cells with gangliosides. Furthermore, 
sulfatide did not block brain cell binding to 
laminin (fig.4). It seems possible that laminin, as a 
multifunctional protein, has different binding sites 
in different cells. The differences in TLC overlay 
assays with laminin are probably due to a higher 
salt concentration (250 mM ionic strength) used in 
a previous study [18]. 
The role of the GD~A and GTia gangliosides in 
laminin-neuron interactions appears especially in- 
teresting. Studies with a different type of model as 
compared to the present study have suggested that 
the GD~A ganglioside is required for neuritic 
growth in the neuroblastoma cell line GOT0 [20]. 
Interestingly, the content of the GD~A ganglioside 
in developing brain is strongly increased at the time 
of extensive neuritic growth [21]. 
Gangliosides have been previously shown to in- 
hibit adhesive phenomena [ 16,22-241. Recent 
studies by Cheresh et al. 1241 have indicated that 
gangliosides have a general role in cell adhesion in 
providing the electrostatic environment required in 
cell binding to various proteins, like collagen, 
fibronectin and laminin. Whether the ganglioside 
inhibition in the case of laminin-neuron interaction 
reflects the general effect of gangliosides on 
adhesive phenomena or a more specific competi- 
tion with the cell surface ganglioside receptors is 
not yet known. At any event, because laminin 
binds to the gangliosides that are found in high 
content at the neuronal cell surfaces, it seems 
reasonable to suggest that the gangliosides or 
similar carbohydrate chains found in glycoproteins 
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[25] are involved in the laminin-neuron interac- 
tions that initiate neuritic growth. 
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